Community-Acquired Spontaneous Bacterial Peritonitis in Adults Not Responding to Initial Antibiotic Therapy
Clinical scenario
Adults (age ≥18) with community-acquired spontaneous bacterial peritonitis diagnosed by ascitic fluid polymorphonuclear leukocyte (PMN) count >250/mm³, without nosocomial or healthcare-associated infection and without sepsis or septic shock.
First-line treatment — failure condition
Initial empirical therapy with an IV third-generation cephalosporin did not achieve the required response: ascitic fluid PMN count did not decrease by at least 25% from baseline on diagnostic paracentesis performed 48 hours after starting antibiotic treatment.
This protocol defines the next step when that response threshold is not met.
Next-step approach
When the 48-hour PMN response criterion is not achieved, management involves broadening antibiotic coverage to agents with a wider spectrum. Evaluation to exclude secondary bacterial peritonitis is also warranted. The full antibiotic selection and clinical algorithm are available in the complete protocol.
References
DOI: 10.1002/hep.31884
- The diagnosis of SBP/SBE is established with a fluid polymorphonuclear (PMN) leukocyte count >250/mm³.
- First-line empirical antibiotic therapy for community-acquired SBP/SBE is IV third-generation cephalosporin.
- A negative response is defined by a decrease in PMN count <25% from baseline and should lead to broadening the antibiotic spectrum and investigating secondary peritonitis (abdominal imaging studies).
- A decrease in fluid PMN <25% from baseline indicates lack of response and should lead to broadening of antibiotic coverage and further evaluation to rule out secondary bacterial peritonitis.
View source ↗